Janus Henderson Global Life Sciences Fund returned 18.66% and the MSCI World Health Care Index SM returned 10.60%.

There is no doubt that Viktor Orbán’s anti-Ukrainian campaign before the parliamentary elections is a classic example of the instrumentalization of foreign policy for the internal mobilization of the ...

Physical AI is rapidly advancing, with the potential to transform trillion-dollar industries, from manufacturing to the ...

Plummeting literacy rates have fueled a bitter debate over how best to teach reading. And artificial intelligence turning up ...

Q4 gross margin rose 110 basis points to 27.8%, a new record, with Liquor segment gross margin at 26% in Q4 and 25.9% for the ...

The silent hero of every flight: the seat fabrics that regulate temperature, provide comfort, and often go unnoticed by passengers.

Good morning, and welcome to SNDL's Fourth Quarter 2025 Financial Results Conference Call. This morning, SNDL issued a press release announcing their financial results for the fourth quarter of 2025 ...

Every year the event grows more elite - this year's 34th edition will feature an A list including Dua Lipa, Nikki Glaser, Quinta Brunson and a performance by Lola Young - but its mission to raise ...

As the next AI wave unfolds, Europe’s position as a commercial first-wave AI laggard may actually prove to be a strength.

Multifaceted strategy to achieve profitability includes: expanded software and mobility revenue streams, manufacturing scale, rigorous capital allocation, and material cost reduct ...

As we close 2025 and enter what we expect to be a defining year for Allogene Therapeutics, Inc., the environment around us is shifting. Cell therapy has entered a phase defined by evidence, where ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.